483
Asclemed USA Inc. dba Enovachem PharmaceuticalsFDA 483 - Asclemed USA Inc. dba Enovachem Pharmaceuticals - September 25, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Asclemed USA Inc., dba Enovachem, a packer/repacker in Torrance, CA, received a Form 483 with three observations during an inspection from September 25-27, 2018. The observations primarily concern deficiencies in equipment calibration, lack of written procedures for annual product evaluations, and incomplete Certificates of Analysis for repackaged APIs. These issues indicate potential gaps in quality control and documentation practices.
- Inspection Date
- September 25, 2018
- Product Type
- Drugs
Open in Dashboard
ID · ccf2a7b4-c2c7-4665-9a4d-826fc53bb90e